Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine series.
Saved in:
| Title: | Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine series. |
|---|---|
| Authors: | Sherman AC; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: acsherman@bwh.harvard.edu., van Haren SD; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Borberg E; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Swank Z; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Aleissa M; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia., Tong A; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA., Rooks R; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA; Emory School of Medicine, Atlanta, GA, USA., Kanwal U; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA., Levine H; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA., Yates B; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA., Izaguirre N; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA., Ryff K; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA., Thomas S; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Parisi L; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA., Li X; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA., Walt DR; Harvard Medical School, Boston, MA, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Levy O; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Broad Institute of MIT & Harvard, Cambridge, MA, USA., Walsh SR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Issa NC; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Baden LR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. |
| Source: | Vaccine [Vaccine] 2024 Sep 17; Vol. 42 (22), pp. 126054. Date of Electronic Publication: 2024 Jun 10. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38862310 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine series. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sherman+AC%22">Sherman AC</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: acsherman@bwh.harvard.edu.<br /><searchLink fieldCode="AU" term="%22van+Haren+SD%22">van Haren SD</searchLink>; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Borberg+E%22">Borberg E</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Swank+Z%22">Swank Z</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Aleissa+M%22">Aleissa M</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Tong+A%22">Tong A</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rooks+R%22">Rooks R</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA; Emory School of Medicine, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Kanwal+U%22">Kanwal U</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Levine+H%22">Levine H</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Yates+B%22">Yates B</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Izaguirre+N%22">Izaguirre N</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ryff+K%22">Ryff K</searchLink>; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+S%22">Thomas S</searchLink>; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Parisi+L%22">Parisi L</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Walt+DR%22">Walt DR</searchLink>; Harvard Medical School, Boston, MA, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Levy+O%22">Levy O</searchLink>; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Broad Institute of MIT & Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Walsh+SR%22">Walsh SR</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Issa+NC%22">Issa NC</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Baden+LR%22">Baden LR</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2024 Sep 17; Vol. 42 (22), pp. 126054. <i>Date of Electronic Publication: </i>2024 Jun 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38862310 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.vaccine.2024.05.081 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 126054 Titles: – TitleFull: Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine series. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sherman AC – PersonEntity: Name: NameFull: van Haren SD – PersonEntity: Name: NameFull: Borberg E – PersonEntity: Name: NameFull: Swank Z – PersonEntity: Name: NameFull: Aleissa M – PersonEntity: Name: NameFull: Tong A – PersonEntity: Name: NameFull: Rooks R – PersonEntity: Name: NameFull: Kanwal U – PersonEntity: Name: NameFull: Levine H – PersonEntity: Name: NameFull: Yates B – PersonEntity: Name: NameFull: Izaguirre N – PersonEntity: Name: NameFull: Ryff K – PersonEntity: Name: NameFull: Thomas S – PersonEntity: Name: NameFull: Parisi L – PersonEntity: Name: NameFull: Li X – PersonEntity: Name: NameFull: Walt DR – PersonEntity: Name: NameFull: Levy O – PersonEntity: Name: NameFull: Walsh SR – PersonEntity: Name: NameFull: Issa NC – PersonEntity: Name: NameFull: Baden LR IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 09 Text: 2024 Sep 17 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1873-2518 Numbering: – Type: volume Value: 42 – Type: issue Value: 22 Titles: – TitleFull: Vaccine Type: main |
| ResultId | 1 |
